Search results for " RADIOTHERAPY"

showing 10 items of 156 documents

The SCOPE of definitive chemoradiotherapy in locally advanced esophageal cancer: what direction for the future?

2016

Exclusive chemoradiotherapy (CRT) delivering 50 Gy over 5 weeks with cisplatin and fluorouracil-based chemotherapy is a cornerstone in locally advanced esophageal cancer or non-operable patients since the results of the pivotal study of US Intergroup RTOG-8501 (1). This trial has successfully demonstrated that some patients with esophageal carcinoma may be long-term survivors so that this treatment is now definitely accepted as curative (2). Nevertheless the prognosis is still very disappointing with a 5-year overall survival rate of approximately 25%. Attempts to improve overall survival by escalating the dose of radiotherapy with concurrent cisplatin and fluorouracil has been assessed in …

0301 basic medicinePulmonary and Respiratory MedicineOncologymedicine.medical_specialtymedicine.medical_treatmentLocally advancedCetuximab[SDV.CAN]Life Sciences [q-bio]/CancerOutcomes[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract[ SDV.CAN ] Life Sciences [q-bio]/CancerIntensity-Modulated Radiotherapy03 medical and health sciences0302 clinical medicineInternal medicineCarcinomaMedicineComputingMilieux_MISCELLANEOUSCapecitabineCisplatinChemotherapybusiness.industryCarcinomaInduction ChemotherapyEsophageal cancermedicine.diseaseRadiation-Therapy3. Good healthRadiation therapyEditorial030104 developmental biologyChemoradiationFluorouracil030220 oncology & carcinogenesisIi Randomized-TrialCisplatinbusiness[ SDV.MHEP.PSR ] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractChemoradiotherapymedicine.drug
researchProduct

A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice

2020

Antigen-encoding, lipoplex-formulated RNA (RNA-LPX) enables systemic delivery to lymphoid compartments and selective expression in resident antigen-presenting cells. We report here that the rejection of CT26 tumors, mediated by local radiotherapy (LRT), is further augmented in a CD8+ T cell-dependent manner by an RNA-LPX vaccine that encodes CD4+ T cell-recognized neoantigens (CD4 neoantigen vaccine). Whereas CD8+ T cells induced by LRT alone were primarily directed against the immunodominant gp70 antigen, mice treated with LRT plus the CD4 neoantigen vaccine rejected gp70-negative tumors and were protected from rechallenge with these tumors, indicating a potent poly-antigenic CD8+ T cell r…

0301 basic medicinemedicine.medical_treatmentT cellImmunology03 medical and health sciences0302 clinical medicineAntigenmedicineImmunology and Allergyrna-lpxcd4+ t cellsradiotherapyRC254-282Antitumor activityLiposomeintegumentary systembusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensRNARC581-607Radiation therapy030104 developmental biologymedicine.anatomical_structureOncologyLocal radiotherapy030220 oncology & carcinogenesisCancer researchImmunologic diseases. Allergybusinesscancer vaccinesneoantigensCD8OncoImmunology
researchProduct

Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma

2003

BACKGROUND. The acknowledged effectiveness of vinblastine, bleomycin, and methotrexate (VBM) chemotherapy in patients with early-stage Hodgkin lymphoma has been associated with conflicting toxicity reports. METHODS. One hundred forty-three patients were evaluated clinically and had favorable Stage IA or IIA Hodgkin lymphoma. Ninety-three patients were treated with the standard VBM schedule combined with extended-field radiotherapy (EFRT), leaving the choice of the therapeutic sequence free. Fifty subsequent patients were treated with a slightly modified VBM schedule (VbMp) combined with RT limited to involved fields (IF-RT) and delivered only after the end of chemotherapy. In the VbMp sched…

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentPulmonary toxicitymedicine.drug_classmedicine.medical_treatmentchemotherapyBleomycinGastroenterologyAntimetaboliteBleomycinchemistry.chemical_compoundHodgkinPrednisoneInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLungradiotherapyAgedChemotherapybusiness.industryHodgkin; chemotherapy; radiotherapy; toxicitytoxicityMiddle AgedCombined Modality TherapyHodgkin DiseaseSurgeryVinblastineRegimenMethotrexateTreatment OutcomeOncologychemistryVincristineFemaleMethotrexateNeoplasm Recurrence Localbusinessmedicine.drugCancer
researchProduct

Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma.

2002

Abstract Purpose: To evaluate the effectiveness of stereotactic fractionated radiotherapy (SFRT) in the treatment of optic nerve sheath meningioma (ONSM). Methods and Materials: Between 1994 and 2000, a total of 39 patients with either primary ( n = 15) or secondary ( n = 24) ONSM were treated with SFRT and received a median total tumor dose of 54 Gy using 1.8 Gy/fraction. Results: The radiographic response to SFRT was documented in all patients as stable disease (no change) except for 1 patient with a partial response. After a median follow-up of 35.5 months, all patients with ONSM were alive without recurrence. The visual fields and visual acuity were improved in 6 of 15 and 1 of 16 exami…

AdultMaleCancer Researchmedicine.medical_specialtyVisual acuityTime FactorsFractionated radiotherapyErythemaAdolescentRadiographyRadiosurgerymedicineHumansRadiology Nuclear Medicine and imagingIn patientAge of OnsetAgedAged 80 and overRadiationbusiness.industryStandard treatmentOptic Nerve NeoplasmsDose fractionationMiddle Agedmedicine.diseaseSurgeryOptic nerve sheath meningiomaTreatment OutcomeOncologyDisease ProgressionFemaleRadiologyDose Fractionation Radiationmedicine.symptombusinessMeningiomaFollow-Up StudiesInternational journal of radiation oncology, biology, physics
researchProduct

Acrometastases to the Hand: A Systematic Review

2021

Background and Objectives: The term acrometastases (AM) refers to secondary lesions sited distally to the elbow and knee, representing 0.1% of all bony metastases. By frequency, pulmonary cancer and gastrointestinal and genitourinary tract neoplasms are the most responsible for the reported AM. Improvements in oncologic patient care favor an increase in the incidence of such rare cases. We performed a systematic review of acrometastases to the hand to provide further insight into the management of these fragile patients. We also present a peculiar case of simultaneous acrometastasis to the ring finger and pathological vertebral fracture. Material and Methods: A literature search according t…

AdultMaleMedicine (General)medicine.medical_specialtyLung NeoplasmsAdolescentmedicine.medical_treatmentBone NeoplasmsWristMetastasisFingersYoung AdultFinger PhalangesR5-920Breast cancerThumb metastasesmedicineCarcinomaChemotherapyHumansChildAgedAged 80 and overRadiotherapyAcrometastasesbusiness.industryGenitourinary systemIncidence (epidemiology)CarcinomaAcrometastases; Carcinoma; Chemotherapy; Immunotherapy; Radiotherapy; Thumb metastases; Adolescent; Adult; Aged; Aged 80 and over; Child; Female; Fingers; Humans; Male; Middle Aged; Prognosis; Young Adult; Bone Neoplasms; Finger Phalanges; Lung NeoplasmsGeneral MedicineMiddle AgedPrognosismedicine.diseasePrimary tumorRadiation therapymedicine.anatomical_structureFemaleSystematic ReviewImmunotherapyRadiologybusinessMedicina
researchProduct

Radiation-related superficial oral mucoceles : an under-recognized acute toxicity in head and neck cancer patients

2018

Background Acute toxicity is usually defined as adverse changes occurring immediately or a short time after the start of oncological treatment. Material and Methods Cross-sectional retrospective study performed with head and neck cancer patients who underwent radiotherapy from 2013 to 2016. Results Ten (1.2%) patients developed SOMs during radiotherapy, most (80%) of which were men with a mean age of 59.5 years at diagnosis. SOMs mainly affected the floor of the mouth (60%) between the fourth and the sixth weeks of radiation therapy. All lesions were asymptomatic and spontaneously ruptured approximately 9 days after diagnosis. Conclusions Although rare, SOMs may be regarded as an acute oral…

AdultMalemedicine.medical_specialtyCross-sectional studymedicine.medical_treatmentMucoceleAsymptomaticHead and neck radiotherapymedicineCarcinomaHumansRadiation InjuriesGeneral DentistryAgedRetrospective StudiesOral Medicine and Pathologybusiness.industryResearchHead and neck cancerRetrospective cohort studyMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Acute toxicityRadiation therapyCross-Sectional StudiesOtorhinolaryngologyHead and Neck NeoplasmsUNESCO::CIENCIAS MÉDICASAcute DiseaseCarcinoma Squamous CellSurgeryFemaleRadiologymedicine.symptombusinessMouth Diseases
researchProduct

Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center expe…

2018

Background: Several experiences in the literature report SBRT as an effective treatment option for medically inoperable early stage non-small cell lung cancer (NSCLC) and oligometastatic disease. The optimal fractionation schedules and total dose remain controversial. In this study, we evaluated the safety in terms of toxicity and efficacy of using of 8–10 fractions schedules with Helical Tomotherapy (HT) for primary and metastatic lung lesions. Methods: Between March 2014 and May 2016, a total of 39 patients (median age 72 years, range 26–91) were treated with HT-SBRT for malignant lung lesions: 22 patients with early stage NSCLC, 17 with oligometastases. Patients received 8–10 fract…

AdultMalemedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentStereotactic radiation therapyRadiosurgerySingle CenterTomotherapy030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineHelical tomotherapyCarcinoma Non-Small-Cell LungmedicineHumansRadiology Nuclear Medicine and imagingStage (cooking)Lung cancerAgedPneumonitisAged 80 and overSBRTHelical tomotherapy; Lung cancer; Radiotherapy; SBRTRadiotherapybusiness.industryRadiotherapy DosageGeneral MedicineMiddle Agedmedicine.diseaseSurvival RateRadiation therapyTreatment Outcome030220 oncology & carcinogenesisFeasibility StudiesFemaleDose Fractionation RadiationRadiologyLung cancerbusinessTomography Spiral ComputedEsophagitis
researchProduct

Radiosurgery as Treatment for Acoustic Neuroma. Ten Years’ Experience

2013

The acoustic neuroma is a benign tumour that usually affects the vestibular portion of the vestibulocochlear nerve. It represents 8% of all intracranial tumours and 80% of those arising at the cerebellopontine angle. There are 3 treatment options: microsurgery (the technique of choice), radiosurgery and observation. The objective of the study was to evaluate the results and side effects obtained using radiosurgery as treatment for acoustic neuroma.We performed a review of all patients treated with radiosurgery (Gamma Knife and linear accelerator) at doses of 1200-1300 cGy for unilateral acoustic neuroma in our hospital from January 1999 until January 2010. In all patients we evaluated the o…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentAcoustic neuromaRadiosurgeryRadiosurgeryVestibulocochlear nerveStereotactic radiotherapyHearingotorhinolaryngologic diseasesmedicineHumansIntracranial tumoursAgedRetrospective Studiesbusiness.industryTreatment optionsNeuroma AcousticGeneral MedicineMiddle AgedMicrosurgerymedicine.diseaseCerebellopontine angleSurgeryFemalesense organsbusinessActa Otorrinolaringologica (English Edition)
researchProduct

Hippocampal dose during Linac-based stereotactic radiotherapy for brain metastases: An observational study

2017

Abstract Introduction Aim of the present study is to evaluate homolateral and contralateral hippocampus (H-H, C-H, respectively) dose during Fractionated Stereotactic Radiotherapy (FSRT) or Radiosurgery (SRS) for brain metastases (BM). Materials & methods Patients with BM   3 months, were considered for SRS/FSRT (total dose 15–30 Gy, 1–5 fractions). For each BM, a Flattening Filter Free (FFF) Volumetric Modulated Arc Therapy (VMAT) plan was generated with one or two arcs. Hippocampi were not considered during optimizations phase and were contoured and evaluated retrospectively in terms of dose: the Dmedian, Dmean, D0.1cc and the V1Gy, V2Gy, V5Gy and V10Gy were analyzed. Results From April 2…

AdultMalemedicine.medical_treatmentBiophysicsGeneral Physics and AstronomyStereotactic fractionatedHippocampal formationRadiation DosageRadiosurgeryHippocampusRadiosurgery030218 nuclear medicine & medical imagingStereotactic radiotherapyYoung AdultPhysics and Astronomy (all)03 medical and health sciences0302 clinical medicineNuclear Medicine and ImagingStereotactic radiotherapymedicineHumansRadiology Nuclear Medicine and imagingIn patientHippocampiAgedAged 80 and overRadiotherapyBrain Neoplasmsbusiness.industryRadiotherapy DosageBrain metastasesGeneral MedicineMiddle AgedBrain metastases; Hippocampi; Radiotherapy; Stereotactic fractionated; Stereotactic radiotherapy; Biophysics; Radiology Nuclear Medicine and Imaging; Physics and Astronomy (all)Volumetric modulated arc therapyRadiation therapy030220 oncology & carcinogenesisTotal doseFemaleDose reductionParticle AcceleratorsRadiologybusinessNuclear medicinePhysica Medica
researchProduct

The combined operative and radiotherapeutic treatment (CORT) of recurrent tumors infiltrating the pelvic wall: First experience with 18 patients

1992

CORT is a new radiosurgical treatment concept for patients with recurrent gynecologic malignancies infiltrating the pelvic wall. The operative part consists of (i) staging laparotomy; (ii) maximum debulking of the tumor from the pelvic wall and exenteration of infiltrated central pelvic organs; (iii) implantation of brachytherapy guiding tubes on the residual tumor/tumor bed at the pelvic wall; (iv) pelvic wall plasty with muscle and omentum flaps to create a protective distance between the tubes and the pelvic hollow organs and to induce therapeutic angiogenesis; and (v) surgical reconstruction of bowel, bladder, and vulvoperineovaginal functions. Radiation is given postoperatively as frac…

Adultmedicine.medical_specialtyGenital Neoplasms Femalemedicine.medical_treatmentBrachytherapyBrachytherapyWhole-PelvisPelvic wallHumansMedicineProspective StudiesPelvic NeoplasmsPelvic organbusiness.industryPrior RadiationOperative mortalityObstetrics and GynecologyRadiotherapy DosageGeneral MedicineMiddle AgedPrognosisDebulkingCombined Modality TherapySurgeryRadiation therapyOncologyFemalebusinessPelvic radiotherapyInternational Journal of Gynecology & Obstetrics
researchProduct